Published in Am J Trop Med Hyg on October 01, 2005
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis (2008) 3.27
Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis (2010) 1.90
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis (2012) 1.59
Risk factors of visceral leishmaniasis in East Africa: a case-control study in Pokot territory of Kenya and Uganda. Int J Epidemiol (2008) 1.40
Management of visceral leishmaniasis in rural primary health care services in Bihar, India. Trop Med Int Health (2010) 1.25
Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals. Trop Med Int Health (2010) 1.10
Asymptomatic Leishmania infection: a new challenge for Leishmania control. Clin Infect Dis (2014) 1.07
Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent. PLoS Negl Trop Dis (2014) 0.99
Visceral leishmaniasis in rural bihar, India. Emerg Infect Dis (2012) 0.96
Factors associated with Leishmania asymptomatic infection: results from a cross-sectional survey in highland northern Ethiopia. PLoS Negl Trop Dis (2012) 0.94
The effects of host diversity on vector-borne disease: the conditions under which diversity will amplify or dilute the disease risk. PLoS One (2013) 0.93
Survey of domestic cattle for anti-Leishmania antibodies and Leishmania DNA in a visceral leishmaniasis endemic area of Bangladesh. BMC Vet Res (2011) 0.91
Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic. J Clin Microbiol (2011) 0.91
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India. Parasit Vectors (2016) 0.90
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal. PLoS One (2014) 0.87
Host choice of Phlebotomus orientalis (Diptera: Psychodidae) in animal baited experiments: a field study in Tahtay Adiyabo district, northern Ethiopia. Parasit Vectors (2015) 0.86
An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani. BMC Infect Dis (2013) 0.85
Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease. Front Immunol (2014) 0.83
Social and Economic Burden of Human Leishmaniasis. Am J Trop Med Hyg (2016) 0.82
Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent. Pathog Glob Health (2016) 0.80
Trend analysis of visceral leishmaniasis at Addis Zemen health center, Northwest Ethiopia. Biomed Res Int (2014) 0.79
Identification and functional characterization of Leishmania donovani secretory peroxidase: delineating its role in NRAMP1 regulation. PLoS One (2013) 0.76
Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System. Int J Epidemiol (2014) 0.76
Phlebotomine sandfly ecology on the Indian subcontinent: does village vegetation play a role in sandfly distribution in Bihar, India? Med Vet Entomol (2017) 0.75
Challenges in modeling complexity of neglected tropical diseases: a review of dynamics of visceral leishmaniasis in resource limited settings. Emerg Themes Epidemiol (2017) 0.75
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med (1994) 16.32
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ (2003) 11.82
Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg (2003) 8.14
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med (1993) 7.85
Construct design for efficient, effective and high-throughput gene silencing in plants. Plant J (2001) 7.73
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Drug resistance in leishmaniasis. Clin Microbiol Rev (2006) 7.35
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis (2002) 7.17
Total silencing by intron-spliced hairpin RNAs. Nature (2000) 4.78
Leishmaniasis and poverty. Trends Parasitol (2006) 4.25
Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol (1993) 4.05
Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya. Am J Trop Med Hyg (2003) 3.81
Chagas' Disease. N Engl J Med (2015) 3.75
Impact of permethrin-treated bed nets on entomologic indices in an area of intense year-round malaria transmission. Am J Trop Med Hyg (2003) 3.64
Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop (2009) 3.22
Use of handheld computers with global positioning systems for probability sampling and data entry in household surveys. Am J Trop Med Hyg (2007) 3.14
Study on clinico-epidemiological profile of HIV patients in eastern India. J Assoc Physicians India (2006) 2.87
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med (2007) 2.75
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis (2007) 2.74
Risk factors for kala-azar in Bangladesh. Emerg Infect Dis (2005) 2.73
Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis (2009) 2.56
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health (2009) 2.35
Leishmaniasis: new approaches to disease control. BMJ (2003) 2.30
Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ (2010) 2.30
Effect of permethrin-treated bed nets on the spatial distribution of malaria vectors in western Kenya. Am J Trop Med Hyg (2003) 2.28
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res (2011) 2.21
Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment. Am J Trop Med Hyg (2003) 2.20
Implications of the western Kenya permethrin-treated bed net study for policy, program implementation, and future research. Am J Trop Med Hyg (2003) 2.20
Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis (2011) 2.19
Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis (2006) 2.17
The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya I. Development of infrastructure and description of study site. Am J Trop Med Hyg (2003) 2.13
High incidence of zidovudine induced anaemia in HIV infected patients in eastern India. Indian J Med Res (2010) 2.11
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis (2005) 2.06
Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community. Am J Trop Med Hyg (2003) 2.04
A systematic review and meta-regression analysis of aggression during the first episode of psychosis. Acta Psychiatr Scand (2013) 2.01
Demonstration of pulmonary arteries by contrast injection into pulmonary vein. Br Heart J (1978) 1.99
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg (2010) 1.93
Patients with suspected myocardial infarction: effect of mode of referral on admission time to a coronary care unit. Br J Gen Pract (1992) 1.92
Patterns and predictors of hospitalisation in first-episode psychosis. Prospective cohort study. Br J Psychiatry (2001) 1.87
Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85
Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategies. Am J Trop Med Hyg (2010) 1.81
Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem (2004) 1.79
Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg (2010) 1.74
Fecal contamination of drinking water within peri-urban households, Lima, Peru. Am J Trop Med Hyg (2007) 1.72
Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh. Clin Infect Dis (2010) 1.71
Is Dhat culture bound? Br J Psychiatry (1992) 1.68
Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis (2011) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis (2011) 1.64
Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health (2008) 1.63
Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis (2010) 1.61
Oral prostaglandin E2 in ductus-dependent pulmonary circulation. Circulation (1981) 1.61
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health (2008) 1.59
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis (2012) 1.59
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug Resist Updat (2006) 1.58
Endocrine changes in male HIV patients. J Assoc Physicians India (2011) 1.56
Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. J Acquir Immune Defic Syndr (2010) 1.55
Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis (2007) 1.53
Drug resistance in leishmaniasis. J Glob Infect Dis (2010) 1.52
Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol (2007) 1.50
Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol (2011) 1.49
Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infect Genet Evol (2008) 1.49
Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. J Clin Microbiol (2011) 1.48
ABC of atrial fibrillation. Drugs for atrial fibrillation. BMJ (1995) 1.48
Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP). Acta Trop (2009) 1.47
Burden of malaria at community level in children less than 5 years of age in Togo. Am J Trop Med Hyg (2006) 1.46
Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis (2003) 1.46
Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. Thorax (1996) 1.46
Ethnicity in psychiatric epidemiology: need for precision. Br J Psychiatry (1997) 1.45
Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Am J Trop Med Hyg (2007) 1.44
IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol (2011) 1.44
Determinants of OmpF porin antigenicity and structure. J Biol Chem (1990) 1.44
Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis (2011) 1.42
Evolution of the ferric enterobactin receptor in gram-negative bacteria. J Bacteriol (1991) 1.41
Rapid scale-up of long-lasting insecticide-treated bed nets through integration into the national immunization program during child health week in Togo, 2004. Am J Trop Med Hyg (2010) 1.41
Knowledge, attitude, and practices related to Kala-azar in a rural area of Bihar state, India. Am J Trop Med Hyg (2006) 1.40
Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis (2008) 1.40
Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. Clin Infect Dis (2007) 1.39
Left ventricular diastolic function in hypertensive patients with unstable angina and single coronary artery disease. Am J Hypertens (1995) 1.39
Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol (2008) 1.39
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg (2009) 1.38
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient. Tuber Lung Dis (1995) 1.37
Identification of the cryptosporidium pig genotype in a human patient. J Infect Dis (2002) 1.36
A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics (2006) 1.36
Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res (2005) 1.36
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis (2010) 1.35
Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med Int Health (2006) 1.35
Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. Am J Trop Med Hyg (2009) 1.34
Correlation between CD4 counts of HIV patients and enteric protozoan in different seasons - an experience of a tertiary care hospital in Varanasi (India). BMC Gastroenterol (2008) 1.34
Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.34
The economic impact of visceral leishmaniasis on households in Bangladesh. Trop Med Int Health (2006) 1.34
Diarrhea, CD4 counts and enteric infections in a hospital - based cohort of HIV-infected patients around Varanasi, India. BMC Infect Dis (2006) 1.33
IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis (2011) 1.33
Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect Immun (2006) 1.33
Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther (2000) 1.32